Search -

Displaying 1 - 11 of 11

Sort: Relevancy | Date

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

September 01, 2025

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

December 22, 2020

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

News Daily News

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Michael O'Riordan

October 27, 2020

Study Affirms Thrombotic Risk in COVID-19

News Daily News

Study Affirms Thrombotic Risk in COVID-19

October 01, 2020

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

News Daily News

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

Michael O'Riordan

August 28, 2020

COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death

News Daily News

COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death

July 23, 2020

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

News Daily News

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

Michael O'Riordan

April 29, 2020

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

News Conference News ESC 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

August 26, 2018

News Daily News

Single-Center Studies Build Case for Venous Angioplasty in Multiple Sclerosis

April 05, 2012

News Daily News

Surgery Safer Than Endovascular Procedure for Form of Chronic Arteritis

March 21, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.